79 FR 37 pgs. 10527-10528 - Proposed Data Collections Submitted for Public Comment and Recommendations

Type: NOTICEVolume: 79Number: 37Pages: 10527 - 10528
Docket number: [60-Day 14-0004]
FR document: [FR Doc. 2014-04021 Filed 2-24-14; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version:  PDF Version
Pages: 10527, 10528

[top] page 10527

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day 14-0004]

Proposed Data Collections Submitted for Public Comment and Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-7570 or send comments to Leroy Richardson, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30333; comments may also be sent by email to omb@cdc.gov.

Comments are invited on (a) whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have a practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarify of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of information technology. Written comments should be received within 60 days of this notice.

Proposed Project

National Disease Surveillance Program II. Disease Summaries (0920-0004 Exp. 8/31/2014)-Revision-National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC).

Background and Brief Description

CDC requests a three year approval for a Revision of the National Disease Surveillance Program II. Disease Summaries information collection.

Proposed revisions include shifting information collection management responsibilities to the National Center for Immunization and Respiratory Diseases (NCIRD) and consolidating various forms to reflect more current technology trends. Also, CDC requests the use of the following new Influenza forms to enhance surveillance and assist in understanding the complexities of these newer viruses: Human Infection with Novel Influenza A Virus Severe Outcomes; Human Infection with Novel Influenza A Virus with Suspected Avian Source; and Antiviral Resistant Influenza Infection Case Report Form.

Due to the uncertainty regarding MERS-CoV and its threat to human health, CDC also has a need to use a Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [Patient Under Investigation] form. Use of an Adenovirus Typing Report Form and discontinuing the use of the Harmful Algal Bloom-related Illness form is also requested. The Adenovirus Typing Report Form allows for a passive surveillance mechanism that collects adenovirus typing data to enhance adenovirus circulation data already collected by the National Respiratory and Enteric Virus Surveillance System (NREVSS).

The methodology for reporting varies depending on the occurrence, modes of transmission, infectious agents, and epidemiologic measures.

There is no cost to respondents other than their time.

The total estimated annualized burden hours are 31,921.

page 10528


[top] 
Type of respondents state epidemiologists Form name Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours)
Foodborne Outbreak Form (CDC 52.13) 54 32 20/60 576
Influenza virus (Internet; year round) (CDC 55.31) 35 52 10/60 303
-Influenza virus (electronic, year round) (PHLIP) 49 52 5/60 212
-Influenza virus (electronic, year round) (PHIN-MS) 3 52 5/60 13
U.S. WHO Collaborating Laboratories Influenza Testing Methods Assessment (CDC 55.31A) 87 1 10/60 15
Weekly Influenza-like Illness (year round) (CDC 55.20) 1,800 52 10/60 15,600
Daily Influenza-like illness (year round) 75 365 10/60 4,563
Influenza-Associated Pediatric Death Case Report Form 57 2 30/60 57
Novel Influenza A Virus Case Screening Form 57 1 15/60 14
Novel Influenza A Virus Infection Contact Tracing Form 57 1 30/60 29
Human Infection with Novel Influenza A Virus Case Report Form 57 6 30/60 171
Novel and Pandemic Influenza A Virus Case Status Summary 57 1 15/60 14
Human Infection with Novel Influenza A Virus Severe Outcomes 57 1 1.5 86
Human Infection with Novel Influenza A Virus with Suspected Avian Source 57 1 30/60 29
122 CMRS-City health officers or vital statistics registrars (daily) 58 365 12/60 4,234
122 CMRS-City health officers or vital statistics registrars (weekly) 122 52 12/60 1,269
Aggregate Hospitalization and Death Reporting Activity Weekly Report Form 56 52 10/60 485
Antiviral Resistant Influenza Infection Case Report Form 57 3 30/60 86
National Enterovirus Surveillance Report: (CDC 55.9) (electronic) 25 12 15/60 75
National Respiratory & Enteric Virus Surveillance System (NREVSS) (CDC 55.83A, B, NREVSS Lab Assessment Form, D) (electronic) 300 52 15/60 3,900
Adenovirus Typing Report Form 25 12 15/60 75
Middle East Respiratory Syndrome Coronavirus (MERS) Patient Under Investigation (PUI) Form 57 3 25/60 71
Suspected Viral Gastroenteritis (Calicivirus surveillance) 20 5 15/60 25
Waterborne Diseases Outbreak Form (CDC 52.12) 57 1 20/60 19
Total 31,921


Leroy A. Richardson,

Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.

[FR Doc. 2014-04021 Filed 2-24-14; 8:45 am]

BILLING CODE 4163-18-P